Yazar "Loirat, D." için PubMed İndeksli Yayınlar Koleksiyonu listeleme
-
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
Dent, R.; André, F.; Gonçalves, A.; Martin, M.; Schmid, P.; Schütz, F.; Kümmel, S.; Swain, S.M.; Bilici, Ahmet; Loirat, D.; Villalobos, Valencia R.; Im, S. A.; Park, Y. H.; De Laurentis, M.; Colleoni, M.; Guarneri, V.; Bianchini, G.; Li, H.; Kirchmayer Machackova, Z.; Mouta, J.; Deurloo, R.; Gan, X.; Fan, M.; Mani, A.; Swat, A.; Cortés, J. (2024)Background: Immune checkpoint inhibitors improve the efficacy of first-line chemotherapy for patients with programmed death-ligand 1 (PD-L1)-positive unresectable locally advanced/metastatic triple-negative breast cancer ...